idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
idw - Informationsdienst
Wissenschaft
Former patients can contribute their experiences to cancer research; registration for the course is open until 10 April.
According to the Robert Koch Institute, more than half a million people in Germany are diagnosed with cancer every year. Clinical trials are a central component of modern cancer medicine: they enable the development of new therapies and the improvement of existing treatments. Nevertheless, relatively few patients have so far taken part in clinical trials, often due to a lack of information or uncertainty regarding the process, benefits and risks. This is where the new StudienHelfer programme from the Comprehensive Cancer Center Lower Saxony (CCC-N) comes in.
Course Structure and Registration
The StudienHelfer programme is aimed at former cancer patients, their relatives and anyone else interested, and aims to involve those affected more closely in clinical research and make active use of their experiences. The course runs for approximately two months and takes place mainly online, supplemented by two in-person sessions in Hanover and Göttingen. Participants are expected to be willing to attend regularly and to be interested in actively contributing to support for those affected or to study planning after the course ends. Participation is free of charge; registration is required by 10 April 2026. Full details are available at: http://www.ccc-niedersachsen.eu/studienhelfer
Participants gain a basic understanding of clinical trials and learn how to support other patients with their queries, as well as how to contribute their perspective to the planning of new trials. In doing so, they make an important contribution to more patient-centred cancer research. The modular programme covers, amongst other things, the fundamentals of clinical trials, trial designs and forms of treatment, patient safety, and the ethical and legal framework. The programme is complemented by insights into the decision-making processes of trial participants, patient involvement in research, and practical aspects of trial development.
The CCC-N brings together Göttingen University Hospital (UMG) and Hannover Medical School (MHH) and is one of 14 leading oncology centres in Germany funded by German Cancer Aid.
SERVICE
Further information can be found here: https://www.ccc-niedersachsen.eu/studienhelfer
For further information, please contact Dr Sarah Knippenberg, Knippenberg.Sarah@mh-hannover.de.
Two patients discussing the new StudienHelfer programme and the opportunity to share their own exper ...
Copyright: UMG/Ronald Schmidt
Merkmale dieser Pressemitteilung:
Journalisten
Medizin
überregional
Buntes aus der Wissenschaft, Organisatorisches
Englisch
Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.
Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).
Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.
Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).
Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).
